Evolving Strategies for the Management of Persistent Atrial Fibrillation
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Electrophysiology and Cardiovascular Physiology".
Deadline for manuscript submissions: 31 March 2026
Special Issue Editor
2. St Georges University Hospital NHS Foundation Trust, London SW17 0QT, UK
3. Ashford & St Peters Hospitals NHS Foundation Trust, Surrey KT16 0PZ, UK
Interests: atrial fibrillation; arrhythmias; catheter ablations
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore the latest therapeutic approaches for managing persistent atrial fibrillation (AF), with particular emphasis on catheter-based and surgical interventions. It also highlights emerging technologies, including advanced mapping and imaging techniques, which enhance the assessment and treatment of AF by improving patient selection and procedural precision. Further focus is given to the management of patients with coexisting conditions, such as heart failure, cardiomyopathies, and other significant comorbidities, which often complicate AF treatment. The issue includes a comprehensive review of global clinical outcomes and regional variations in the management of AF. In addition, the issue addresses important aspects of training for healthcare professionals and considerations for the effective delivery of care, aiming to support high standards and consistency in AF treatment worldwide.
Dr. Riyaz Kaba
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- persistent atrial fibrillation
- heart failure
- cardiomyopathies
- technology
- comorbidities
- imaging
- mapping
- ablation
- surgery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
